EWM
Essex Woodlands Management Portfolio holdings
AUM $279M
1-Year Return
29.39%
This Quarter Return
-6.76%
1 Year Return
+29.39%
3 Year Return
+195.65%
5 Year Return
+90.32%
10 Year Return
+273.6%
AUM
$201M
AUM Growth
-$50.2M
(-20%)
Cap. Flow
-$2.19M
Cap. Flow
% of AUM
-1.09%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
8
New
–
Increased
2
Reduced
–
Closed
–
Top Buys
| 1 |
ELGX
Endologix Inc
ELGX
|
+$1.16M |
| 2 |
EyePoint Pharmaceuticals
EYPT
|
+$9.42K |
Top Sells
| 1 |
CORI
Corium International, Inc.
CORI
|
+$3.36M |
Sector Composition
| 1 | Healthcare | 99.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
EyePoint Pharmaceuticals
EYPT
$924M
| $75M | 37.35% |
4,190,922
+526
| +0% | +$9.42K |
|
2
Axogen
AXGN
$753M
| $57.7M | 28.73% |
2,739,751
| – | – |
|
|
RVNC
3
DELISTED
Revance Therapeutics, Inc.
RVNC
| $52.7M | 26.22% |
3,342,047
| – | – |
|
4
MediciNova
MNOV
$60.8M
| $9.69M | 4.82% |
1,170,370
| – | – |
|
|
CORI
5
DELISTED
Corium International, Inc.
CORI
| – | – |
0
| – | -$3.36M |
|
|
ELGX
6
DELISTED
Endologix Inc
ELGX
| $1.29M | 0.64% |
1,257,468
+1,131,721
| +900% | +$1.16M |
|
7
Gyre Therapeutics
GYRE
$718M
| $640K | 0.32% |
10,483
| – | – |
|
|
ACUR
8
DELISTED
Acura Pharmaceuticals Inc
ACUR
| $352K | 0.18% |
1,956,397
| – | – |
|